<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp> is an increasing public health problem that is expected to escalate in the future due to the growing incidence of <z:hpo ids='HP_0001513'>obesity</z:hpo> in the western world </plain></SENT>
<SENT sid="1" pm="."><plain>While this disease is well known for its devastating effects on the kidneys and vascular system, diabetic individuals can develop cardiac dysfunction, termed diabetic <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo>, in the absence of other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> such as <z:hpo ids='HP_0000822'>hypertension</z:hpo> or <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>While much effort has gone into understanding the effects of elevated <z:chebi fb="105" ids="17234">glucose</z:chebi> or altered insulin sensitivity on cellular components within the heart, significant changes in the cardiac extracellular matrix (ECM) have also been noted </plain></SENT>
<SENT sid="3" pm="."><plain>In this review article we highlight what is currently known regarding the effects <z:mp ids='MP_0002055'>diabetes</z:mp> has on both the expression and chemical modification of proteins within the ECM and how the fibrotic response often observed as a consequence of this disease can contribute to reduced cardiac function </plain></SENT>
</text></document>